Lenvatinib 10mg capsules
NHS hospitals in England used £24,259,814 of indicative cost of Lenvatinib 10mg capsules in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 6.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Lenvatinib 10mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Lenvatinib 10mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £1,579,694 |
| Cambridge Univ Hosp Nhs Foundation Trust | £1,331,237 |
| The Royal Marsden Nhs Foundation Trust | £1,325,777 |
| East And North Hertfordshire Nhs Trust | £1,193,860 |
| The Clatterbridge Cancer Centre Nhs Ft | £962,790 |
| Barts Health Nhs Trust | £788,721 |
| Sheffield Teaching Hospitals Nhs Trust | £747,192 |
| Univ Hpl B/Ham Nhs Foundation Trust | £734,499 |
| Nottingham University Hospitals Trust | £723,338 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £722,476 |
The primary-care picture
Lenvatinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Lenvatinib medicine page.